• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gastroenterol Hepatol . Diarrhea and Altered Inflammatory Cytokine Pattern in Severe COVID-19: Impact on Disease Course and In-Hospital Mortality

tetano

Editor, Senior Moderator
J Gastroenterol Hepatol


. 2020 Jun 29.
doi: 10.1111/jgh.15166. Online ahead of print.
Diarrhea and Altered Inflammatory Cytokine Pattern in Severe COVID-19: Impact on Disease Course and In-Hospital Mortality

Lei Zhang[SUP] 1 [/SUP], Chaoqun Han[SUP] 1 [/SUP], Shengyan Zhang[SUP] 1 [/SUP], Caihan Duan[SUP] 1 [/SUP], Haitao Shang[SUP] 1 [/SUP], Tao Bai[SUP] 1 [/SUP], Xiaohua Hou[SUP] 1 [/SUP]


AffiliationsExpand

Abstract

Background: Dynamic changes of immunocyte subsets and inflammatory profiles in coronavirus disease 2019(COVID-19) patients with gastrointestinal symptoms were undetermined.
Methods: A single center retrospective analysis of 409 severe hospitalized COVID-19 patients from Jan 20 to Feb 29, 2020 was performed. The longitudinal characteristics of immune inflammatory cytokines in patients with/without diarrhea were analyzed. The relations of diarrhea and immuno-inflammatory factors with illness course and clinical outcomes were further explored.
Results: Diarrhea was more common and more serious with longer duration (4.9 ? 1.5 days vs 4.2 ? 1.5 days, P=0.039) and higher frequency (5.5 ? 2.1 times/day vs 4.0 ? 2.0 times/day, P=0.001) in deceased patients than in the survivors. Also, diarrhea patients were more inclined to develop multi-organ damage, who had longer illness course (media 41.0 days vs 36.0 days, P=0.052) and hospital stays (media 27.0 days vs 23.0 days, P=0.041) in survivors, and higher mortality (33.0% vs 22.6%, P=0.045) and earlier death (media 20.0 days vs 25.0 days, P=0.038) in the deceased patients. Progressively neutrophilia and lymphopenia, especially the declined CD8[SUP]+[/SUP] T cells, were demonstrated in diarrhea patients relative to the non-diarrhea cases. The inflammatory cytokines including IL-6, IL-10 and TNF-α were intensively increased in patients with diarrhea. The multivariable logistic analysis showed longer duration of diarrhea (P=0.036), higher neutrophil counts (P=0.011) and lower lymphocyte counts (P<0.001) were independent risk factors of in-hospital death. The proportional hazards model indicated longer duration of diarrhea (P=0.002), higher frequency of diarrhea (P=0.058), higher neutrophil counts (P=0.001), lower lymphocyte counts (P=0.035) and decreased proportion of CD8+ T cells (P<0.001) were independently associated with longer illness course of the survivors.
Conclusions: Diarrhea patients were more likely to present with neutrophilia, lymphopenia and cytokine storm, and to develop multi-organ damage. The inflammatory patterns were independent factors associated with illness course of the survivors and in-hospital death of severe COVID-19.

Keywords: Coronavirus disease 2019; SARS-CoV-2; diarrhea; digestive system; immuno-inflammatory.
 
Back
Top Bottom